Skip to main content
. 2022 Feb 18;12:836379. doi: 10.3389/fcimb.2022.836379

Table 5.

Combination therapy against polymicrobial biofilms.

Drug combinations Bacteria interacting with C. albicans Effect on polymicrobial biofilm Reference
Polymyxin and amphotericin B P. aeruginosa Combination of amphotericin B and highest concentration of polymyxin could eradicate polymicrobial biofilms Rodrigues et al. (2017)
Flucloxacillin, ciprofloxacin and fluconazole S. aureus and P. aeruginosa Combination of all three drugs was required to inhibit all three microbes in the biofilm Townsend et al. (2017)
Anidulafungin and tigecycline S. aureus Synergism against in vivo intra-abdominal biofilms Rogiers et al. (2018)
2-aminobenzimidazole and curcumin S. aureus Increased biofilm inhibition by combination Tan et al. (2019)
Caspofungin and polymyxin B P. aeruginosa Combination was able to significantly reduce the total biomass of mixed biofilms Fernandes et al. (2020)
Antifungal chalcone-based derivative and antibacterial polycyclic anthracene-maleimide adduct S. aureus Synergistic biofilm inhibition Bonvicini et al. (2021)
Berberine and amphotericin B S. aureus Synergistic biofilm inhibition with reduced hyphal formation and adhesion Gao et al. (2021)
Farnesol combined with myricetin, C135* and compound 1771** S. mutans Eliminated bacteria from dual species biofilm Lobo et al. (2021)
C135 and fluoride S. mutans Eliminated bacteria from dual species biofilm Lobo et al. (2021)
Bacterial biosurfactant and DNase S. epidermidis Synergistic activity against biofilms Srikanth et al. (2021)

*4-OH chalcone.

**5-phenyl-1,3,4-oxadiazol-2-yl)carbamoyl]methyl 2-{naphtho[2,1-b]furan-1-yl}acetate).